LRRC14 Activators
LRRC14 activators constitute a putative class of compounds that may influence the activity or expression of the leucine-rich repeat-containing protein 14 (LRRC14) through indirect modulation of cellular signaling pathways. This class of activators does not interact with LRRC14 directly but instead affects various upstream pathways that can lead to alterations in the function or levels of LRRC14 within the cell. The mechanisms by which these activators operate are diverse and hinge on the modulation of distinct signaling cascades or cellular processes. For example, some activators might increase intracellular cAMP, thereby activating protein kinase A (PKA), which can phosphorylate target proteins and impact numerous cellular functions, including altering the expression or activity of LRRC14. Other activators might influence epigenetic regulation, such as DNA methylation and histone acetylation, thus changing gene expression profiles and conceivably affecting LRRC14.
The spectrum of these activators ranges from small molecule inhibitors of enzymes, like histone deacetylases or DNA methyltransferases, to signaling molecule analogs and ionophores that perturb the cellular ionic balance. For instance, ionomycin acts by increasing intracellular calcium levels, a crucial second messenger in many signaling pathways, and could thus indirectly affect LRRC14's role within the cell. Compounds like forskolin, which elevate cAMP levels, and phorbol esters, which activate protein kinase C (PKC), are also considered part of this chemical class due to their broad effects on cell signaling. Each compound within this class holds the capacity to influence various aspects of cellular homeostasis, which may include modulation of transcriptional activity, protein stability, and intracellular signaling pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to an increase in cAMP levels, which can modulate various signaling pathways, potentially affecting LRRC14 by altering protein kinase A (PKA) activity and downstream signaling events. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is involved in a multitude of cellular functions. Activation of PKC can lead to changes in phosphorylation status of proteins and might impact LRRC14 indirectly through altered cell signaling. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
A cell-permeable cAMP analog that activates PKA. By mimicking cAMP, it can potentiate the PKA signaling pathway and possibly influence the function or localization of LRRC14 indirectly. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
A calcium ionophore that increases intracellular calcium levels, possibly affecting calcium-dependent signaling pathways that could have downstream effects on LRRC14. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that can lead to the accumulation of ubiquitinated proteins, potentially affecting the degradation pathway of LRRC14, thus indirectly influencing its levels and activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, which can lead to changes in gene expression patterns. It might indirectly affect LRRC14 expression by altering the epigenetic state of the cells. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An inhibitor of histone deacetylases, leading to altered chromatin structure and potentially changing the expression patterns of genes, including those that may encode LRRC14 or its regulators. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits glycogen synthase kinase-3 (GSK-3), a negative regulator of the Wnt signaling pathway, which might influence LRRC14 indirectly if LRRC14 is part of or regulated by Wnt signaling components. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
A metabolite of vitamin A that regulates gene expression. Through its action on nuclear receptors, it can alter the transcription of genes and might have an indirect effect on LRRC14 expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
A polyphenol found in green tea with multiple effects on signal transduction pathways, potentially affecting LRRC14 indirectly through its broad action on cell signaling and metabolism. | ||||||